NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 218 filers reported holding NEVRO CORP in Q3 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $15,000 | -11.8% | 331 | +38.5% | 0.00% | – |
| Q1 2022 | $17,000 | -15.0% | 239 | -4.0% | 0.00% | – |
| Q4 2021 | $20,000 | +33.3% | 249 | +88.6% | 0.00% | – |
| Q3 2021 | $15,000 | -58.3% | 132 | -39.4% | 0.00% | – |
| Q2 2021 | $36,000 | +176.9% | 218 | +139.6% | 0.00% | – |
| Q1 2021 | $13,000 | -56.7% | 91 | -46.8% | 0.00% | – |
| Q4 2020 | $30,000 | +25.0% | 171 | -1.7% | 0.00% | – |
| Q3 2020 | $24,000 | +20.0% | 174 | +3.0% | 0.00% | – |
| Q2 2020 | $20,000 | +400.0% | 169 | +267.4% | 0.00% | – |
| Q3 2019 | $4,000 | -20.0% | 46 | -37.0% | 0.00% | – |
| Q2 2019 | $5,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q1 2019 | $5,000 | 0.0% | 73 | -37.6% | 0.00% | – |
| Q4 2018 | $5,000 | -28.6% | 117 | 0.0% | 0.00% | – |
| Q3 2018 | $7,000 | -22.2% | 117 | 0.0% | 0.00% | – |
| Q2 2018 | $9,000 | +800.0% | 117 | +1571.4% | 0.00% | – |
| Q1 2018 | $1,000 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,776,368 | $45,155,275 | 1.48% |
| ARMISTICE CAPITAL, LLC | 2,356,000 | $59,889,520 | 0.87% |
| Rock Springs Capital Management LP | 1,211,400 | $30,793,788 | 0.73% |
| ArrowMark Colorado Holdings LLC | 1,817,189 | $46,192,944 | 0.51% |
| Palo Alto Investors LP | 186,259 | $4,734,704 | 0.38% |
| K2 PRINCIPAL FUND, L.P. | 51,000 | $1,296,420 | 0.30% |
| TD Capital Management LLC | 84,648 | $2,151,752 | 0.26% |
| Point72 Europe (London) LLP | 73,800 | $1,875,996 | 0.25% |
| Venator Management LLC | 25,000 | $636 | 0.23% |
| Virtus Investment Advisers, Inc. | 12,500 | $317,750 | 0.22% |